Amino Collective

Amino Collective is a Berlin, Germany-based early-stage venture capital firm dedicated to investing in the health and bio sectors. The firm distinguishes itself as a "collective" of experienced founders, operators, and investors, aiming to support life-changing ideas in the healthcare landscape. Their investment thesis is sharply focused on innovative companies that are poised to disrupt or significantly improve various facets of health and biotechnology, reflecting a deep commitment to advancing human well-being through technology and science.

The firm primarily targets early-stage companies, including those at the pre-seed, seed, and Series A stages. Amino Collective typically deploys initial investments ranging from €200,000 to €1,000,000, equivalent to approximately $216,000 to $1,080,000 USD based on recent exchange rates. Beyond capital injection, Amino Collective emphasizes providing strategic support and leveraging their collective expertise to help portfolio companies navigate challenges, scale operations, and achieve their growth milestones. This hands-on approach is a core part of their value proposition to founders.

Amino Collective's portfolio showcases a diverse array of companies spanning digital health, biotech, diagnostics, therapeutics, MedTech, FemTech, longevity, nutrition, mental health, and AI in health. Their investments include well-known European health tech players such as Kaia Health, Clue, and Temedica, among others. This broad yet specialized focus underscores their ambition to be a leading partner for entrepreneurs building the future of health. The firm's strategic location in Berlin also positions it at the heart of Europe's burgeoning tech and biotech ecosystem, enabling strong connections within the regional startup community.